Μαυροβούνιο - Κροατικά - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"osmi red-d" d.o.o. podgorica - oftalmološka i optička medicinska sredstva

Μαυροβούνιο - Κροατικά - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"osmi red-d" d.o.o. podgorica - oftalmološka i optička medicinska sredstva

Κροατία - Κροατικά - HALMED (Agencija za lijekove i medicinske proizvode)

stallergenes, 6 rue alexis de tocqueville, antony, francuska - suhi ekstrakt alergena iz peludi trava: čvoraste oštrice (dactylis glomerata l.), obične mirisavke (anthoxanthum odoratum l.), višegodišnjeg ljulja (lolium perenne l.), livadne vlasnjače (poa pratensis l.) i livadne mačice (phleum pratense l.) suhi ekstrakt alergena iz peludi trava: čvoraste oštrice (dactylis glomerata l.), obične mirisavke (anthoxanthum odoratum l.), višegodišnjeg ljulja (lolium perenne l.), livadne vlasnjače (poa pratensis l.) i livadne mačice (phleum pratense l.) - sublingvalna tableta - urbroj: jedna sublingvalna tableta sadrži 100 ir ili 300 ir ekstrakta alergena iz peludi trava: čvoraste oštrice (dactylis glomerata l.), obične mirisavke (anthoxanthum odoratum l.), višegodišnjeg ljulja (lolium perenne l.), livadne vlasnjače (poa pratensis l.) i livadne mačice (phleum pratense l.)

Κροατία - Κροατικά - HALMED (Agencija za lijekove i medicinske proizvode)

stallergenes, 6 rue alexis de tocqueville, antony, francuska - suhi ekstrakt alergena iz peludi trava: čvoraste oštrice (dactylis glomerata l.), obične mirisavke (anthoxanthum odoratum l.), višegodišnjeg ljulja (lolium perenne l.), livadne vlasnjače (poa pratensis l.) i livadne mačice (phleum pratense l.) - sublingvalna tableta - urbroj: jedna sublingvalna tableta sadrži 300 ir ekstrakta alergena iz peludi trava: čvoraste oštrice (dactylis glomerata l.), obične mirisavke (anthoxanthum odoratum l.), višegodišnjeg ljulja (lolium perenne l.), livadne vlasnjače (poa pratensis l.) i livadne mačice (phleum pratense l.)

Ευρωπαϊκή Ένωση - Κροατικά - EMA (European Medicines Agency)

biogen netherlands b.v. - natalizumab - multipla skleroza - selektivni imunosupresivi - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 i 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Κροατία - Κροατικά - HALMED (Agencija za lijekove i medicinske proizvode)

stallergenes, 6 rue alexis de tocqueville, antony, francuska - standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides pteronyssinus standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides farinae - sublingvalna tableta - urbroj: jedna sublingvalna tableta sadrži 100 ir ili 300 ir standardiziranog alergenog ekstrakta grinja kućne prašine dermatophagoides pteronyssinus i dermatophagoides farinae u jednakim dijelovima

Κροατία - Κροατικά - HALMED (Agencija za lijekove i medicinske proizvode)

stallergenes, 6 rue alexis de tocqueville, antony, francuska - standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides pteronyssinus standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides farinae - sublingvalna tableta - urbroj: jedna sublingvalna tableta sadrži 100 ir standardiziranog alergenog ekstrakta grinja kućne prašine dermatophagoides pteronyssinus i dermatophagoides farinae

Κροατία - Κροατικά - HALMED (Agencija za lijekove i medicinske proizvode)

stallergenes, 6 rue alexis de tocqueville, antony, francuska - standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides pteronyssinus standardiziran ekstrakt alergena grinja kućne prašine dermatophagoides farinae - sublingvalna tableta - urbroj: jedna sublingvalna tableta sadrži 300 ir standardiziranog alergenog ekstrakta grinja kućne prašine dermatophagoides pteronyssinus i dermatophagoides farinae

Ευρωπαϊκή Ένωση - Κροατικά - EMA (European Medicines Agency)

sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 i 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Ευρωπαϊκή Ένωση - Κροατικά - EMA (European Medicines Agency)

mylan ireland limited - финголимод hidroklorid - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 i 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.